|
Video: What is a Stock Split?
|
|
Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company that develops, manufactures, markets, and distributes a portfolio of medicines, including generics, injectables, biosimilars and specialty branded pharmaceuticals. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services. According to our Amneal Pharmaceuticals stock split history records, Amneal Pharmaceuticals has had 0 splits. | |
|
Amneal Pharmaceuticals (AMRX) has 0 splits in our Amneal Pharmaceuticals stock split history database.
Looking at the Amneal Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amneal Pharmaceuticals shares, starting with a $10,000 purchase of AMRX, presented on a split-history-adjusted basis factoring in the complete Amneal Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/08/2018 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$14.71 |
|
End price/share: |
$6.05 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-58.87% |
|
Average Annual Total Return: |
-13.83% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,113.98 |
|
Years: |
5.97 |
|
|
|
|
|